A common method used to diagnose localised prostate cancer one of the...The team said: The PSA value for the period after the diagnosis i...Men with localised prostate cancer have in general a good chance o...Katja Fall of Karolinska Institutet said there was a need to find...Previous research has indicated a link between how quickly a tumou...
A common method used to diagnose localised prostate cancer, one of the more common cancers among men, may be// less effective than previously believed, researchers at Sweden's Karolinska Institutet said.
Researchers measured concentrations of prostate-specific antigen (PSA) in the blood of a group of cancer patients and monitored the development of the disease in a study that was part of the Scandinavian Prostate Cancer Group collaboration.
The team said: "The PSA value for the period after the diagnosis is insufficient as a method of distinguishing with any certainty the men who will develop a fatal cancer from those with a slower tumour growth."
Men with localised prostate cancer have in general a good chance of survival even without treatment. However, many undergo major surgery or radiotherapy, which carries the risk of impaired sexual function and incontinence.
Katja Fall of Karolinska Institutet said there was a need to "find better methods of separating the patients who will develop malignant prostate cancer from those with a more benign disease".
Previous research has indicated a link between how quickly a tumour grows and the speed with which blood levels of PSA increase in the first stages of the cancer.
Fall and her colleagues monitored 267 men from Sweden, Finland and Iceland who were diagnosed with prostate cancer between 1989 and 1999.
The PSA values measured in the first two years after diagnosis were used to describe the appearance of the early PSA curve for each patient.
At the follow-up in late 2003, 34 patients had died of prostate cancer and 18 had developed metastases.
Neither the PSA reading nor the speed with which it increased during these first two years "was able to screen out with any certainty which patients would have needed intensive treatment from amongst those who would have managed just as well without," the study said.
'"/>
(Date:7/8/2008)...Pa., July 8 /PRNewswire/ -- The following statemen...rroway Topaz & Kessler, LLP:, Notice is hereby gi...nited States District Court for the Middle Distric...rities of Healthways Inc. (Nasdaq: HWAY ),("Healt...ough February 26,2008, inclusive (the "Class Peri...
(Date:7/8/2008)...ns Cite Patient Concerns about Delays in Oxygen Or..., July 8 /PRNewswire-USNewswire/ -- The new Medica... equipment has created,concern and chaos for benef..., and home medical equipment providers across the ...n areas on July 1., The bidding program has trigg...
(Date:7/8/2008)...N, July 8, 2008) The American Society of Hematolo...ents of its Alternative Training Pathway Grant. Th...encourage the development and implementation of no...mas Abshire, MD, of Emory University, Donald Mahon...id Sternberg, MD, PhD, of Mount Sinai School of Me...
(Date:7/8/2008)...lure Study Validates Use of Pharos Innovation,s Pr...to Reduce Healthcare Utilization and ...uly 8 /PRNewswire/ -- Pharos Innovations, a pionee...clinical and financial,performance improvement thr...ounced today the results from the Iowa Medicaid Co...
...n to the body after the first few minutes of exerc...ew minutes // of exercise, the amount of oxygen p...e heart carries the oxygen to the blood. Research...ages 55 and 75 who had mild hypertension. Research...
...y should be the treatment of choice for heart atta...o to doesn’t offer angioplasty// services and they...eatment. Research has shown heart attack patients ...ngioplasty to open up the clogged blood vessel tha...
... study researchers say the drug gabapentin (Neuron...ve preventive // measure for people with chronic d...leptic drug. Studies have also shown its success i...ues like diabetic neuropathy, postherpetic neuralg...
...or people with high blood pressure and heart failu...at put them at higher risk for heart attacks and s...bout 9,000 men and women from the Heart Outcomes P... older and suffering from heart-related problems o...
(Date:7/8/2008)...es Using Emisphere,s Eligen(R) ... /- Emisphere,Technologies,...om a clinical,study assessing the oral delivery of...sed a delivery-agent-based approach using Emispher...versity Hospital in Basel, Switzerland,by Christop...
(Date:7/8/2008)...ontrol versus Concerta from 30 minutes to six ho... Only Focalin XR provided onset of effect as early...ggests Focalin XR provides comparable efficacy to ... Symptoms of Attention Deficit/Hyperactivity Disor...ity to focus and learn in an educational ...
(Date:7/7/2008)... ANA598 and ANA773 Acting via Independent... Conference Call Today at 2:00 PM PDT, SA...harmaceuticals,Inc. (Nasdaq: ANDS ) announced to...the Toll-Like Receptor-7 (TLR7) mechanism for the,...ical pharmacology testing,and the results of compl...
(Date:7/7/2008)...vidence supporting accuracy of, its biospectrosc...onal conference., BA...re/ -- Molecular,Biometrics, LLC, a privately-held...ols for applications in personalized medicine to m...ealth and disease, presented data from,four new st...
...May 14, 2007 - Acceleron Pharma,Inc., a biopharma...reatment of musculoskeletal, metabolic and cancer-...clinical study with,ACE-031 that demonstrated the ...d strength in normal mice and in murine models of,...lators of muscle,to increase muscle mass and stren...
...rket dynamics offers insights into,what will be ne...ients, NEW YORK, May 14, 2007 /PRNewswire-USNewsir...(TB Alliance), a not-for-profit,product developme...lopment of new TB drugs, today released results fr...f the global TB drug market,that offers a detailed...
...toscope System incorporates the latest Olympus des...ments for diagnostic and therapeutic procedures. T...d nurses to assemble the most dynamic instrument f...m incorporates uses stainless steel and Teflon, en...
...tem uses Cooled ThermoTherapy® (transurethral ...cisely targeted microwave energy deep into hyperpl...s for durable clinical outcomes. Dual parameter fe...ctal temperatures for optimal therapeutic intrapro...
Fast, accurate SpO2 measurements always within reach.